A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis

ConclusionA new risk score system for patients with first recurrence of stage 4 neuroblastoma aged ≥18 months at diagnosis is proposed.

Source: Cancer Medicine - October 19, 2019 Category: Cancer & Oncology Authors: Kiana Kreitz, Angela Ernst, Ren é Schmidt, Thorsten Simon, Matthias Fischer, Ruth Volland, Barbara Hero, Frank Berthold Tags: ORIGINAL RESEARCH Source Type: research